This inventor holds 3 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Dietrich Boese: Innovator in Oncological Pharmaceutical Development
Introduction
Dietrich Boese is a notable inventor based in Erzhausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating oncological diseases. With a total of 3 patents, his work has garnered attention in the scientific community.
Latest Patents
Boese's latest patents include innovative compounds that serve as inhibitors for specific cancer-related proteins. One of his patents focuses on "Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors." This invention relates to new [1,3]diazino[5,4-d]pyrimidines and their derivatives, which are designed to inhibit HER2 and its mutants. The patent outlines their use in pharmaceutical compositions and as medicaments for the treatment and prevention of oncological diseases. Another significant patent is for "Benzimidazole compounds and derivatives as EGFR inhibitors." This invention encompasses compounds that inhibit mutant EGFR, providing potential therapeutic options for oncological conditions.
Career Highlights
Dietrich Boese is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on innovative drug development, particularly in oncology. His contributions have been instrumental in advancing the understanding and treatment of various cancers.
Collaborations
Throughout his career, Boese has collaborated with esteemed colleagues, including Harald Engelhardt and Mark Petronczki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Dietrich Boese's work in the field of pharmaceuticals, particularly in developing inhibitors for oncological diseases, showcases his innovative spirit and dedication to improving patient outcomes. His contributions through patents and collaborations continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile